This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

CHS

Authoring team

Chediak-Higashi syndrome is a rare autosomal recessive disorder.

The clinically important features are:

  • severe immune deficiency
  • predisposition to lymphoreticular malignancy
  • neuropathy
  • bleeding diathesis

The underlying cause for these defects is an abnormality in the structure and function of subcellular membranes (1q43 mutation). A similar defect is seen in the Hermansky-Pudlak syndrome.

  • risk of haemophagocytic lymphohistiocytosis is estimated at 85% (2)
  • clinical history in CHS is typically remarkable for recurrent and severe bacterial infections since childhood
    • skin and respiratory tract are mainly involved; Staphylococcus and Streptococcus are the species most frequently isolated
  • patients who survive into early adulthood may develop motor and sensory neuropathies, balance abnormalities, ataxia, tremor, absent deep-tendon reflexes, and low cognitive abilities. In addition, neurologic symptoms can also be observed in older patients presenting with an atypical, milder form of CHS, manifesting with dementia, parkinsonism, peripheral neuropathy

Reference:

  • 1) Ramsay, M.. Protein trafficking violations. Nature Genet. 1996;14:242-244.
  • 2) Introne WJ, Westbroek W, Golas GA, Adams D. In: GeneReviews. Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editor. Seattle (WA): University of Washington, Seattle; 2009. Chediak-Higashi syndrome.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.